乙醛脱氢酶1在宫颈癌发生发展中作用的研究进展

doi:10.13481/j.1671-587x.20170139

[1] Ginestier C, Hur MH, Charafe-Jauffret E, et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J].Cell Stem Cell, 2007, 1(5):555-567.
[2] Levi BP, Yilmaz OH, Duester G, et al. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems[J].Blood, 2009, 113(8):1670-1680.
[3] Hess DA, Wirthlin L, Craft TP, etal. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells[J]. Blood, 2006, 107(5):2162-2169.
[4] Cheung AM, Wan TS, Leung JC, et al. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential[J].Leukemia, 2007,21(7):1423-1430.
[5] Tomita H, Tanaka K, Tanaka T,et al. Aldehyde dehydrogenase 1A1 in stem cells and cancer[J].Oncotarget, 2016,7(10):11018-11032.
[6] Yanagawa Y, Chen JC, Hsu LC, et al. The transcriptional regulation of human aldehyde dehydrogenaseⅠ gene. The structural and functional analysis of the promoter[J].J Biol Chem, 1995, 270(29):17521-17527.
[7] Deng S, Yang X, Lassus H, et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1(ALDH1), in human epithelial cancers[J]. PLoS One, 2010, 5(4):e10277.
[8] Kastan MB,Schlaffer E,Russo JE,etal.Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells[J]. Blood, 1990,75(10):1947-1950.
[9] Jones RJ, Collector MI, Barber JP, et al.Characterization of mouse lymphohematopoietic stem cells lacking spleencolony-forming activity[J]. Blood, 1996, 88(2):487-491.
[10] Chute JP, Muramoto GG, Whitesides J, et al.Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells[J]. Proc Natl Acad Sci U S A, 2006, 103(31):11707-11712.
[11] Corti S, Locatelli F, Papadimitriou D,etal.Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity[J].Stem Cells, 2006,24(4):975-985.
[12] Liu SY, Zheng PS. High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer[J]. Oncotarget, 2013, 4(12):2462-2475.
[13] Chen YC, Chen YW, Hsu HS, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer[J]. Biochem Biophys Res Commun, 2009, 385(3):307-313.
[14] Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer[J]. Mol Cancer Res, 2009, 7(3):330-338.
[15] Kim H, Lapointe J, Kaygusuz G,et al.The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer[J]. Cancer Res,2005,65(18):8118-8124.
[16] Li C, Heidt DG, Dalerba P, et al.Identification of pancreatic cancer stem cells[J].Cancer Res, 2007, 67(3):1030-1037.
[17] Seigel GM, Campbell LM, Narayan M, et al. Cancer stem cell characteristics in retinoblastoma[J]. Mol Vis, 2005, 11:729-737.
[18] Pearce DJ, Taussig D, Simpson C, et al. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples[J]. Stem Cells, 2005, 23(6):752-760.
[19] Dylla SJ, Beviglia L, Park IK, et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy[J]. PLoS One, 2008, 3(6):e2428.
[20] Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis[J]. Cancer Res, 2009, 69(8):3382-3389.
[21] Kuroda T, Hirohashi Y, Torigoe T, et al. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis[J]. PLoS One, 2013, 8(6):e65158.
[22] Rao QX, Yao TT, Zhang BZ, et al. Expression and functional role of ALDH1 in cervical carcinoma cells[J]. Asian Pac J Cancer Prev, 2012, 13(4):1325-1331.
[23] Kohn FR,Sladek NE. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines[J]. Biochem Pharmacol, 1985, 34(19):3465-3471.
[24] Magni M,Shammah S, Schiró R, et al. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer[J]. Blood, 1996, 87(3):1097-1103.
[25] Moreb JS,Gabr A.Retinoic acid down-regulates aldehyde dehydrogenaseand increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde[J].Pharmacol Exp Ther,2005,312(1):339-345.
[26] Honoki K, Fujii H, Kubo A, et al. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance[J]. Oncol Rep, 2010, 24(2):501-505.
[27] 冯敏清,周晖,彭永排,等. 耐放疗宫颈癌Caski细胞ALDH-1表达的研究[J].临床和实验医学杂志,2012,11(7):526-529.
[28] Chen J, Xia Q, Jiang B, etal. Prognostic value of cancer stem cell marker ALDH1 expression in colorectal cancer:A Systematic Review and Meta-Analysis[J].PLoS One, 2015, 10(12):e0145164.
[29] Huo W, Du M, Pan XY, et al. Prognostic value of ALDH1 expression in lung cancer:a meta-analysis[J]. Int J Clin Exp Med, 2015, 8(2):2045-2051.
[30] Yao TT, Chen Q, Zhang BZ,et al. The expression of ALDH1 in cervical carcinoma[J]. Med Sci Monit, 2011, 17(8):HY21-26.
[31] Lin J, Liu X, Ding D, et al. Evidence for epithelial-mesenchymal transition in cancer stem-like cells derived from carcinoma cell lines of the cervix uteri[J]. Int J Clin Exp Pathol, 2015, 8(1):847-855.

Progress research on role of ALDH1 in occurrence and development of cervical cancer

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10

[1]	Hong LI,Panpan YU,Zouyu ZHAO,Chongfeng SUN,Hui QIAO,Ping YANG. Expression of GSTO1 in ovarian cancer tissue and effect of N-glycosylation site mutations on biological behaviors of epithelial ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 469-482.
[2]	Teng LIU,Ning ZHANG,Mingyuan HE,Guanghui CHENG. Research progress in treatment principles for endometrial cancer and its postoperative and postoperative recurrent radiotherapy [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1747-1754.
[3]	Ming CHEN,Qinghua LUO,Hongguang JIN,Liang HAN. Atypical lipomatous tumor of left lower limb: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1384-1389.
[4]	Rongmian YAN,Xinting SUN,Xin GUAN,Yu CHENG,Liying HAN. Effects of KLK5 overexpression on growth of subcutaneous xenograft tumor and cisplatin sensitivity in nude mice [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1194-1203.
[5]	Xialing HUANG,Dandan ZHANG,Xuemei ZHANG. Analysis on relationship between methylation of MSX1 gene and clinical pathological features and prognosis of patients with cervical cancer [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 749-756.
[6]	Yanyan LU,Xiangbo XU,Yamei WU,Yuqi LIU,Han WANG,Lijuan YANG,Zhenjiang WANG,Zishen XIAO,Yanbo LIU. Eosinophil infiltration in cervical lesion and cervical cancer tissues and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1691-1702.
[7]	Chunjing LIU,Yujie YANG,Wei ZHAO,Lijing LIU,Na WANG. Effect of silencing CDC20 on proliferation and cell cycle of endometrial cancer cells by inhibiting Wnt/β-catenin signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1305-1312.
[8]	Changji ZHU,Xingzhe LIU,Yanhua XUAN. Effect of hypoxia on expressions of Gli1 and Sox2 in cervical cancer SiHa cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 442-450.
[9]	Rongxia JIA,Xu ZHOU,Zhikun SHI,Meijing BAO,Guanqun WANG,Yuqing CHU,Yang LIN. Analysis on risk factors for disease progression of patients with cervical intraepithelial neoplasia Ⅰ [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1528-1534.
[10]	Guowu WANG,Yuan YAO,Yu ZHANG,Na XU,Fang LIU. Inhibitory effect of miR-152 on proliferation and invasion of endometrial carcinoma cells by reducing low-density lipoprotein receptor expression [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 591-599.
[11]	Xingyu ZHAO,Xin YANG,Zhihua ZHU,Han HE,Zitong SONG,Wei ZHANG. Inhibitory effect of juglone on proliferation of cervical cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 348-355.
[12]	Aiping WEN,Le LUO,Zhiwei MENG,Jingji JIN,Honggui ZHOU,Jihong ZHU. Expression of Tip60 protein in endometrial adenocarcinoma tissue and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1244-1249.
[13]	Dongli ZHANG,Ruifang FU,Guixia SUN. Effect of oxymatrine on proliferation and apoptosis of cervical cancer SiHa cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 951-957.
[14]	Lijing QIN,Bing HAN,Zhongqi LI,Qi SUO,Zhen JIA,Hongli CUI,Weiqiang XU,Fang FANG,Zhicheng WANG. Effects of targeting-silenced ATRX on cell cycle arrest and apoptosis induced by radiation in cervical cancer HeLa cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 904-910.
[15]	Dan SU, Yi LIU, Manman CUI, Nian YANG, Yu HUANG, Wenjing HE. Evaluation of clinical effect of screening chemotherapy regimens in treatment of ovarian cancer based on miniPDX animal models [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 731-739.